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Abstract
Purpose Multimodality imaging represents an area of rapid
growth with important professional implications for both
radiologists and nuclear medicine physicians throughout
Europe. As a preliminary step for future action aimed at
improving the quality and accessibility of PET-SPECT/CT
multimodality imaging practice in Europe, the European
Society of Radiology (ESR) and the European Association
of Nuclear Medicine (EANM) performed a survey among the
individual memberships of both societies to obtain informa-
tion on the status of multimodality imaging in their facilities
and their future visions on training for combined modalities.
Methods A questionnaire was forwarded to all individual
members of ESR and EANM. The main subject matter of the
questionnaire related to: (1) study performance, current
procedures and current equipment, including its supervisory
personnel at respondents’ individual facilities, and (2) vision
offuturepractice, performance and the potential for combined
interdisciplinary viewing and trainingfor futureprofessionals.
Results The reporting and the billing procedures of multi-
modality imaging studies are very heterogeneous in
European countries. The majority of the members of both
societies believe that the proportion of PET/CT conducted
as a full diagnostic CT with contrast enhancement will
increase over time. As expected, 18F-FDG is the most used
PET tracer for clinical applications. The large majority of
respondents were in favour of an interdisciplinary training
programme, being developed on a European level together
by ESR and EANM and the respective sections of the
European Union of Medical Specialists.
Conclusion The results of this survey show that there is
wide heterogeneity in the current practice of multimodality
imaging in Europe. This situation may limit the full
potential and integration of multimodality imaging within
the clinical arena. There is a strong desire within both
specialties for the development of interdisciplinary training
to address some of these issues.
Keywords Multimodalityimagingsystems.European
SocietyofRadiology.EuropeanAssociationofNuclear
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Introduction
Multimodality imagingrepresents anareaof very rapid growth
with important professional implications. It may be anticipated
that combined functional and anatomical imaging with
positron emission tomography (PET)/computed tomography
(CT), single-photon emission computed tomography
(SPECT)/CT and even PET/magnetic resonance imaging will
play a central part in diagnostic imaging of the near future. In
2007, the European Society of Radiology and the European
Association of Nuclear Medicine published a document
entitled “White Paper of the European Society of Radiology
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(EANM) on Multimodality Imaging” [1, 2]. This paper sets
out the positions and aspirations of ESR and EANM to work
together on an equal and constructive basis for the future
benefit of both specialties on which to build. To provide a
database for these efforts, ESR and EANM performed a
survey among the individual memberships of both societies.
The aim was to obtain information on the status of
multimodality imaging equipment and procedures throughout
Europe, and to identify any future visions on training for
combined modalities amongst respondents.
Methods
A questionnaire was forwarded to all individual members
of ESR and EANM. The questions posed included: (1)
aspects of current practice procedures and equipment at the
individual respondent’s facility and (2) vision on coopera-
tive interdisciplinary training for the future. The question-
naire structure is reported in the Appendix.
Results
A total of 1,841 replies were received: 1,491 from ESR
members (from 38 European countries) and 350 from
EANM members (from 39 countries). The answers to the
questionnaires formed the basis of the currently reported
analysis. The respondents by country and age group are
reported in Tables 1 and 2, respectively. The reporting
(Fig. 1) and the billing (Fig. 2) of multimodality imaging
studies are very heterogeneous. The part of CT in a PET/CT
examination conducted as a full diagnostic CT with or
without intravenous contrast enhancement is presently the
practice in a relatively small number of facilities (Fig. 3).
The majority of respondents of both societies believe that
the proportion of PET/CT conducted as a full diagnostic CT
examination, employing intravenous contrast enhancement
will increase over time (Fig. 4). As expected, oncology is
the most common indication for PET or PET/CT (Fig. 5),
and 18F-FDG is the most used PET tracer for clinical
applications (Table 3). The large majority of the respond-
ents of both societies were in favour of an interdisciplinary
Table 1 Respondents by country.
ESR EANM
Country Number Country Number
Italy 219 France 40
Germany 179 Italy 32
Spain 158 The Netherlands 26
United Kingdom 89 Germany 24
France 74 Turkey 21
The Netherlands 64 Belgium 16
Austria 57 Spain 13
Belgium 52 United Kingdom 12
Poland 51 Greece 11
Greece 50 Portugal 9
Others 498 Others 146
Total 1,491 Total 350
Table 2 Respondents by age group.
Age group (years) ESR (n=1,491) EANM (n=350)
21–30 8% 3%
31–40 30% 23%
41–50 32% 38%
51–60 23% 24%
61+ 7% 12%
Fig. 1 Answers to question 1 of the survey, “In your facility, PET/CT
results are reported by…”
Fig. 2 Answers to question 2 of the survey, “In your facility, PET/CT
results are billed by…”
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together by ESR and EANM and the respective sections of
the European Union of Medical Specialists (Fig. 6). The
majority (65%) of ESR members in favour of the principle
of the interdisciplinary training programme indicated
incorporated training in nuclear medicine and radiology as
their preferred option (Fig. 7). The remaining 35% favoured
an adjusted period of training in the other specialty in
addition to full training in the primary specialty. Among the
EANM members in favour of an interdisciplinary training
programme, 50% indicated as preferred option an adjusted
period of training, and 50% an incorporated training in
nuclear medicine and radiology taking the form of a cross-
over or integrated training programme (Fig. 7).
Discussion
The main purpose of this survey was to collect information
on the practice of multimodality imaging in Europe among
the individual memberships of ESR and EANM. It sought
to address regulatory and supervisory issues, the training
requirements applicable and the comparative roles of
radiologists and nuclear medicine physicians in the various
jurisdictions surveyed.
The general limitations of a pan-European questionnaire
must be taken into account when interpreting the results.
This is particularly so when respondents are chosen from
two independent and fully functioning disciplines as is the
case in this effort. Amongst other factors the questionnaire
value is dependent upon question validity and lack of
ambivalence, and on the care used and bias of respondents.
A certain amount of the reported data may thus not be
representative, but alternative methods of gathering infor-
mation in such a context are difficult, laborious and not
practicable.
The majority of the members of ESR and EANM believe
that the proportion of PET/CT conducted as a full diagnostic
CT with contrast enhancement will increase in the future.
Substantive traininginbothradiologyandnuclear medicineis
Fig. 3 Answers to question 3 of the survey, “How often is the CT part
of PET/CT conducted as a full diagnostic CT+/− contrast enhance-
ment in your facility?”
Fig. 4 Answers to question 4 of the survey, “Do you think that the
proportion of diagnostic CT+/− contrast enhancement will…?”
Fig. 5 Answers to question 5 of the survey, “Does your facility
undertake PET or PET/CT in the following indications?”
Table 3 Answers to question 6 of the survey: radiopharmaceuticals in
clinical use in European countries.
ESR EANM
18F-Fluoro-2-deoxy-D-glucose (FDG) 73% 99%
18F-Dopa 10% 29%
18F-Fluorocholine 10% 23%
18F-Fluoroethyl-L-tyrosine (FET) 5% 12%
18F-Fluorothymidine (FLT) 4% 14%
Other
18F 4% 12%
Any
11C 2% 14%
Rubidium-82 1% 6%
15O-Water 1% 11%
Others 7% 13%
32 Insights Imaging (2010) 1:30–34a prerequisite for high-qualityexamination interpretation with
hybrid systems. There are several ways to achieve such
training, and appropriation of “dual training” structures will
differ between countries relating to differences in infrastruc-
ture and legislation [1, 2]. In addition to being structured and
comprehensive, training should be conducted in accredited
training centres. It should incorporate the principles and
major modalities of both specialties to allow the trainee to
learn the appropriate place of PET-SPECT/CT in the overall
investigative algorithm.
Conclusion
The overall findings of this survey show that there is a wide
heterogeneity in the use and practice of multimodality imaging
in Europe. This situation may well limit the application of the
technique withits fullclinicalpotential. Asclearlyindicated by
the results of the present survey, the large majority of
respondents of both societies were in favour of an interdisci-
plinary training programme, being developed on a European
level together by ESR and EANM and the respective sections
of the European Union of Medical Specialists.
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Appendix
Survey questions
1. In your facility, PET/CT results are reported by
– PET by a nuclear medicine specialist, CT by a
radiologist
– A nuclear medicine physician
– A radiologist
– A dual specialist
– Other
2. In your facility, PET/CT results are billed by
– PET by a nuclear medicine physician, CT by a
radiologist
– A nuclear medicine physician
– A radiologist
– A dual specialist
– Other
3. How often is the CT part of PET/CT conducted as a full
diagnostic CT+/− contrast enhancement in your facility?
– Never
– <20%
– 20–40%
– 40–60%
– 60–80%
– >80%
4. Do you think that the proportion of diagnostic CT+/−
contrast enhancement will
– Increase
– Remain the same
– Decrease
5. Does your facility undertake PET or PET/CT in the
following indications?
– Oncology
– Cardiology
– Neurology
– Infection/inflammation
– Others
6. Which of the following radiopharmaceuticals are in
clinical use in your country?
– 18F-FDG
Fig. 6 Answers to question 6 of the survey, “Which of the following
radiopharmaceuticals are in clinical use in your country?”
Fig. 7 Answers to question 7 of the survey, “Would you be in favour
of an interdisciplinary training programme being developed on a
European level together by ESR and EANM and the respective UEMS
sections?”
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– 18F-Fluorocholine
– 18F-FET
– 18F-FLT
– Other 18F
– Any 11C
– Rubidium-82
– 15O-Water
– Others
7. Would you be in favour of an interdisciplinary training
programme being developed on a European level
together by ESR and EANM and the respective UEMS
sections?
– Yes
(a) Adjusted period of training in the other speciality
in addition to full training in the primary speciality
(b) Integrated training programme: an incorporated
training in nuclear medicine and radiology
taking the form of a cross-over or integrated
training programme
– No
References
1. Gourtsoyiannis N, McCall I, Reiser M, Silberman B, Bischof
Delaloye A, Carrió I et al (2007) White Paper of the European
Society of Radiology (ESR) and the European Association of
Nuclear Medicine (EANM) on Multimodality Imaging. Eur Radiol
17:1926–1930
2. Bischof Delaloye A, Carrió I, Cuocolo A, Knapp W, Gourtsoyian-
nis N, McCall I et al (2007) White Paper of the European
Association of Nuclear Medicine (EANM) and the European
Society of Radiology (ESR) on multimodality imaging. Eur J Nucl
Med Mol Imaging 34:1147–51
34 Insights Imaging (2010) 1:30–34